Prot #HGS1006-C1124: A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated with or without BENLYSTA™ (belimumab)

Project: Research project

Project Details

StatusActive
Effective start/end date10/9/1410/9/21

Funding

  • Outcome Sciences Inc. (Prot #HGS1006-C1124)
  • GlaxoSmithKline LLC (Prot #HGS1006-C1124)